Few & Far Between: Conversations from the Front Lines of Drug Development

Welcome to Few & Far Between! Chris O'Brien, CEO of Biorasi, is your host for Conversations from the Front Lines of Drug Development - from clinical research and policymakers to biotech innovators and industry leaders.

Latest Episodes

61

October 01, 2025 00:45:18
Episode Cover

Episode 61: Woody Bryan, President and CEO of Revolo Biotherapeutics

Why is a feather-light touch important in fighting infections? Find out in our latest episode of the Biorasi Few & Far Between podcast! Host...

Listen

60

September 17, 2025 00:42:11
Episode Cover

Episode 60: Part Two: Yochi Slonim, Co-Founder and CEO at Anima Biotech

Can AI see and talk to human cells? Find out in today's episode of the Biorasi Few & Far Between podcast. Host Chris O'Brien...

Listen

59

September 03, 2025 00:43:41
Episode Cover

Episode 59, Part One: Yochi Slonim, Co-Founder and CEO at Anima Biotech

What do software bugs and human cells have in common? Find out in today's episode of the Biorasi Few & Far Between podcast. Host...

Listen

58

August 14, 2025 00:44:43
Episode Cover

Episode 58: Jerry McLaughlin, CEO and Board Member at Life Biosciences

How does a biopharma background prepare you for the biotech playground? Find out in our latest episode of the Biorasi Few & Far Between...

Listen

57

July 22, 2025 00:44:53
Episode Cover

Episode 57: Jim Brown, DVM, President and CEO of DURECT Corporation

Is the epigenome the "software" of the cell nucleus? Find out in our latest episode of the Biorasi Few & Far Between podcast! Host...

Listen

56

July 15, 2025 00:39:28
Episode Cover

Episode 56, Part Two: Michael Tolentino, MD, Co-Founder and Head Scientific Consultant, Aviceda Therapeutics

How do experienced troubleshooters solve a difficult problem? By asking the right questions first! Welcome back to part two of our conversation with Michael...

Listen
Next